Citations

Mayo Clinic

Showing 10 of 108551 citations.

Artificial intelligence-based classification of echocardiographic views
Naser, Jwan A. , Pislaru, Sorin V. , Tsaban, Gal , Malins, Jeffrey G. , Jackson, John I. , Rostami, Behrouz , López-Jiménez, Francisco , Friedman, Paul A. , Kane, Garvan C. , Sabbah, Michael S. , Lopez-Jimenez, Francisco , Pellikka, Patricia A , Attia, Zachi I , Naser, Jwan A , Lee, Eunjung , Anisuzzaman, DM , Pellikka, Patricia A. , Attia, Zachi I.

European Heart Journal - Digital Health | February 26, 2024 | Volume: 5 | Issue: 3 | Pages: 260-269

10.1093/ehjdh/ztae015 | PMID 38774376 Get It

Abstract Aims Augmenting echocardiography with artificial intelligence would allow for automated assessment of routine parameters and identification of disease patterns not easily recognized otherwise. View classification is an essential first step before deep learning can be applied to the echocardiogram. Methods and results We trained two- and three-dimensional convolutional neural networks (CNNs) using transthoracic echocardiographic (TTE) studies obtained from 909 patients to classify nine view categories (10 269 videos). Transthoracic echocardiographic studies from 229 patients were used in internal validation (2582 videos). Convolutional neural networks were tested on 100 patients with comprehensive TTE studies (where the two examples chosen by CNNs as most likely to represent a view were evaluated) and 408 patients with five view categories obtained via point-of-care ultrasound (POCUS). The overall accuracy of the two-dimensional CNN was 96.8%, and the averaged area under the curve (AUC) was 0.997 on the comprehensive TTE testing set; these numbers were 98.4% and 0.998, respectively, on the POCUS set. For the three-dimensional CNN, the accuracy and AUC were 96.3% and 0.998 for full TTE studies and 95.0% and 0.996 on POCUS videos, respectively. The positive predictive value, which defined correctly identified predicted views, was higher with two-dimensional rather than three-dimensional networks, exceeding 93% in apical, short-axis aortic valve, and parasternal long-axis left ventricle views. Conclusion An automated view classifier utilizing CNNs was able to classify cardiac views obtained using TTE and POCUS with high accuracy. The view classifier will facilitate the application of deep learning to echocardiography.
Association of Shock Indices with Peri-Intubation Hypotension and Other Outcomes: A Sub-Study of the KEEP PACE Trial
Smischney, Nathan J. , Seisa, Mohamed O. , Schroeder, Darrell R. , Schroeder, Darrell , Smischney, Nathan J

Journal of Intensive Care Medicine | February 26, 2024 | Volume: 39 | Issue: 9 | Pages: 866-874

10.1177/08850666241235591 | PMID 38403984 Get It

Background Based on current evidence, there appears to be an association between peri-intubation hypotension and patient morbidity and mortality. Studies have identified shock indices as possible pre-intubation risk factors for peri-intubation hypotension. Thus, we sought to evaluate the association between shock index (SI), modified shock index (MSI), and diastolic shock index (DSI) and peri-intubation hypotension along with other outcomes. Methods The present study is a sub-study of a randomized controlled trial involving critically ill patients undergoing intubation. We defined peri-intubation hypotension as a decrease in mean arterial pressure <65 mm Hg and/or a reduction of 40% from baseline; or the initiation of, or increase in infusion dosage of, any vasopressor medication (bolus or infusion) during the 30-min period following intubation. SI, MSI, and DSI were analyzed as continuous variables and categorically using pre-established cut-offs. We also explored the effect of age on shock indices. Results A total of 151 patients were included in the analysis. Mean pre-intubation SI was 1.0 ± 0.3, MSI 1.5 ± 0.5, and DSI 1.9 ± 0.7. Increasing SI, MSI, and DSI were significantly associated with peri-intubation hypotension (OR [95% CI] per 0.1 increase = 1.16 [1.04, 1.30], P = .009 for SI; 1.14 [1.05, 1.24], P = .003 for MSI; and 1.11 [1.04, 1.19], P = .003 for DSI). The area under the ROC curves did not differ across shock indices (0.66 vs 0.67 vs 0.69 for SI, MSI, and DSI respectively; P = .586). Increasing SI, MSI, and DSI were significantly associated with worse sequential organ failure assessment (SOFA) score (spearman rank correlation: r = 0.30, r = 0.40, and r = 0.45 for SI, MSI, and DSI, respectively, all P < .001) but not with other outcomes. There was no significant impact when incorporating age. Conclusions Increasing SI, MSI, and DSI were all significantly associated with peri-intubation hypotension and worse SOFA scores but not with other outcomes. Shock indices remain a useful bedside tool to assess the potential likelihood of peri-intubation hypotension. Trial registration ClinicalTrials.gov identifier - NCT02105415
Teledermatology in practice: Report of Mayo Clinic experience
Aghazadeh, Nessa , Puiu, Tudor , Mittal, Setu , Hall, Matthew R., Mangold, Aaron R. , Colgan, Michael, Tollefson, Megha M. , Sartori‐Valinotti, Julio C. , Aghazadeh Mohandesi, Nessa , Sokumbi, Olayemi , Colgan, Michael B, Sartori-Valinotti, J C , Mangold, A R , Mittal, Setu , Colgan, Michael B

DIGITAL HEALTH | February 26, 2024 | Volume: 10 | Issue: No issue available | Pages: No page available

10.1177/20552076241234581 | PMID 38410791 Get It

Background Delivery of dermatologic care through telemedicine was accelerated by the COVID-19 pandemic. We sought to analyze the teledermatology experience across Mayo Clinic's health care system to identify strengths and limitations of teledermatology. Methods Electronic health records of dermatology televisits were reviewed from multiple U.S. Mayo Clinic sites from January 2020 through January 2021. Results A total of 13,181 dermatology televisits were conducted in 6468 unique patients. Patients were primarily female (60.2%), and mean age of all patients was 34.1 years. Synchronous / live video conferencing visits were the most common (40.0%) telecare modality. Synchronous / live audio conferencing and asynchronous / store-and-forward visits comprised 33.0% and 27.0% of appointments. In total, 3944 televisits (29.9%) were successfully concluded via a single appointment. An in-person appointment was needed for 1693 patients (26.2%) after their initial televisit. For patients with a single televisit, synchronous / live video conferencing was the most common virtual modality (58.0% vs 32.2% of patients with multiple visits, p < 0.001). Patients needing in-person follow-up visits were slightly older than those who did not (mean [SD], 38.8 [22.3] vs 35.0 [23.6] years; p < 0.001) but without any sex-based difference. Around one-third of patients needed an in-person follow-up visit after their initial asynchronous / store-and-forward visit which was higher when compared with synchronous / live audio and video conferencing. Conclusion Single dermatology televisits effectively managed nearly one-third of patients who did not require in-person follow-up. An initial synchronous / live video conferencing was more likely to yield a single clinical encounter, whereas asynchronous / store-and-forward visits required more in-person follow-up. Future studies are required that focus on dermatology-specific cost, diagnoses, access, quality of care, and outcomes.
Standard-of-Care Treatment for HER2+ Metastatic Breast Cancer and Emerging Therapeutic Options
Premji, Sarah , O’Sullivan, Ciara C. , Premji, Sarah K

Breast Cancer: Basic and Clinical Research | February 26, 2024 | Volume: 18 | Issue: No issue available | Pages: No page available

10.1177/11782234241234418 | PMID 38410761 Get It

Prior to the advent of the HER2-targeted monoclonal antibody trastuzumab, HER2+ breast cancer (BC) was considered an aggressive disease with a poor prognosis. Over the past 25 years, innovations in molecular biology, pathology, and early therapeutics have transformed the treatment landscape. With the advent of multiple HER2-directed therapies, there have been immense improvements in oncological outcomes in both adjuvant and metastatic settings. Currently, 8 HER2-targeted therapies are approved by the Food and Drug Administration (FDA) for the treatment of early-stage and/or advanced/metastatic disease. Nonetheless, approximately 25% of patients develop recurrent disease or metastasis after HER2-targeted therapy and most patients with HER2+ metastatic breast cancer (MBC) die from their disease. Given the many mechanisms of resistance to HER2-directed therapy, there is a pressing need to further personalize care for patients with HER2+ MBC, by the identification of reliable predictive biomarkers, and the development of novel therapies and combination regimens to overcome therapeutic resistance. Of particular interest are established and novel antibody-drug conjugates, as well as other novel therapeutics and multifaceted approaches to harness the immune system (checkpoint inhibitors, bispecific antibodies, and vaccine therapy). Herein, we discuss standard-of-care treatment of HER2+ MBC, including the management of breast cancer brain metastases (BCBM). Furthermore, we highlight novel treatment approaches for HER2+ MBC, including endeavors to personalize therapy, and discuss ongoing controversies and challenges.
Cervical radiculopathy secondary to vertebral artery dissection: clinical features and outcomes
Bucak, Bilal, Essibayi, Muhammed Amir , Holmes, Carmen R. , Keser, Zafer , Keser, Zafer , Essibayi, Muhammed Amir , Casanegra, Ana I. , Lanzino, Giuseppe

Neurological Research | February 26, 2024 | Volume: 46 | Issue: 4 | Pages: 339-345

10.1080/01616412.2024.2321013 | PMID 38402908 Get It

Delayed foreign body reaction to polymethyl methacrylate‐based dermal filler following SARS‐CoV‐2 vaccination
Maredia, Hasina , Campbell, Elliott H. , Munavalli, Girish S., Cohen, Joel L. , Comfere, Nneka I. , Wyles, Saranya P. , Wyles, Saranya

International Journal of Dermatology | February 25, 2024 | Volume: 63 | Issue: 7 | Pages: 966-967

10.1111/ijd.17095 | PMID 38402538 Get It

Safety and pharmacokinetics of ONC201 (dordaviprone) administered two consecutive days per week in pediatric patients with H3 K27M-mutant glioma
Odia, Yazmín , Koschmann, Carl , Vitanza, Nicholas A. , Aguilera, Dolly , Daghistani, Doured , Hall, Matthew D. , Khatib, Ziad, Kline, Cassie , MacDonald, Tobey J. , Mueller, Sabine , Faison, Shamia L., Allen, Joshua E. , Naderer, Odin , Ramage, Samuel , McGovern, Susan L. , Khatua, Soumen , Zaky, Wafik , Kline, Cassie , MacDonald, Tobey , Tarapore, Rohinton S , McGovern, Susan Lynne , Gardner, Sharon L , Koschmann, Carl , Hall, Matthew D , Odia, Yazmin , Blank, Peter M K de , Allen, Jeffrey C. , Tarapore, Rohinton S.

Neuro-Oncology | February 24, 2024 | Volume: 26 | Issue: Supplement_2 | Pages: S155-S164

10.1093/neuonc/noae001 | PMID 38400780 Get It

Abstract Background This study evaluated the safety and pharmacokinetics (PK) of oral ONC201 administered twice-weekly on consecutive days (D1D2) in pediatric patients with newly diagnosed DIPG and/or recurrent/refractory H3 K27M glioma. Methods This phase 1 dose-escalation and expansion study included pediatric patients with H3 K27M-mutant glioma and/or DIPG following ≥1 line of therapy (NCT03416530). ONC201 was administered D1D2 at 3 dose levels (DLs; −1, 1, and 2). The actual administered dose within DLs was dependent on weight. Safety was assessed in all DLs; PK analysis was conducted in DL2. Patients receiving once-weekly ONC201 (D1) served as a PK comparator. Results Twelve patients received D1D2 ONC201 (DL1, n = 3; DL1, n = 3; DL2, n = 6); no dose-limiting toxicities or grade ≥3 treatment-related adverse events occurred. PK analyses at DL2 (D1-250 mg, n = 3; D1-625 mg, n = 3; D1D2-250 mg, n = 2; D1D2-625 mg, n = 2) demonstrated variability in Cmax, AUC0–24, and AUC0–48, with comparable exposures across weight groups. No accumulation occurred with D1D2 dosing; the majority of ONC201 cleared before administration of the second dose. Cmax was variable between groups but did not appear to increase with D1D2 dosing. AUC0–48 was greater with D1D2 than once-weekly. Conclusions ONC201 given D1D2 was well tolerated at all DLs and associated with greater AUC0–48.
Occupational Therapy Practitioners’ Perceptions on Addressing Cognition in Acute Care: A National Survey
Friend, Payton , Trenary, Tamra , Oldenburg, Hannah

Occupational Therapy In Health Care | February 24, 2024 | Volume: 39 | Issue: 2 | Pages: 376-396

10.1080/07380577.2024.2315487 | PMID 38400567 Get It

Risk models in myelofibrosis—the past, present, and future
Tefferi, Ayalew , Vannucchi, Alessandro M. , Vannucchi, Alessandro M

American Journal of Hematology | February 24, 2024 | Volume: 99 | Issue: 4 | Pages: 519-522

10.1002/ajh.27270 | PMID 38400565 Get It

Circadian rhythm and whole gut transit in mice
Laible, Emma, Wegner, Andrew, Knutson, Kaitlyn R. , Kacmaz, Halil, Garramone, Gwyneth K., Gogineni, Kamalika , Matveyenko, Aleksey V. , Linden, David R. , Farrugia, Gianrico , Beyder, Arthur , Knutson, Kaitlyn, Matveyenko, Aleksey, Linden, D R , Beyder, Arthur , Laible, Emma

Neurogastroenterology & Motility | February 24, 2024 | Volume: 36 | Issue: 4 | Pages: No page available

10.1111/nmo.14771 | PMID 38396340 Get It

AbstractBackgroundIn preclinical studies whole gut transit (WGT) in mice is a gold‐standard “leading‐edge” approach that measures the time between orogastric gavage of carmine red and defecation of the first carmine red pellet. Transit studies in humans are performed during the active day because GI motility and transit are suppressed during the night. Since mice are nocturnal, WGT studies traditionally done during the day occur during their rest phase. How circadian rhythm affects WGT in mice is not known.MethodsWe used an automated approach for high temporal resolution uninterrupted testing of mouse WGT and activity. We housed wild‐type Bl6/C57 mice under the standard 12 h light–dark cycles. At 8 weeks, we performed carmine red orogastric gavage and assessed WGT during Light (rest) conditions. Then, we exposed mice to a reverse 12 h light–dark cycle for 2 weeks and tested them in the Dark (active) under red light conditions. Timelapse videos were analyzed to quantify activity and to timestamp all pellets, and multiple parameters were analyzed.Key ResultWhen complementary light cycle reversal experiments were performed, we found a significant increase in mouse activity when mice were tested during their Dark (active) phase, compared to their Light (rest) phase. In mice tested in the Active phase compared to the Rest phase, we found a significant acceleration in WGT, increased rate and total number of pellets produced, and more pellet clustering. These data show that the mice tested in the Active phase have important differences in activity that correlate with multiple alterations in gastrointestinal transit.Conclusion & InferencesDuring the Active phase mice have faster WGT, produce more pellets, and cluster their output compared to testing in the Rest phase. Like in humans, circadian rhythm is an important consideration for transit studies in mice, and a simple reverse light cycle approach facilitates further studies on the role of circadian rhythm in GI motility.